| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 235,239 | 203,352 | 191,706 | 296,599 | | Cost of Revenue | 181,183 | 168,918 | 165,091 | 293,001 | | | Gross Profit | 42,679 | 34,434 | 26,615 | 3,598 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 27,410 | 33,581 | 34,858 | 40,748 | | Non Recurring | 16,496 | 30,307 | 2,629 | 8,800 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,150 | (29,454) | (10,872) | (45,950) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (47) | (140) | 1,328 | (5,450) | | Earnings Before Interest And Taxes | 10,103 | (29,594) | (9,544) | (51,400) | | Interest Expense | 76 | 236 | 296 | 305 | | Income Before Tax | 10,027 | (29,830) | (9,840) | (51,705) | | Income Tax Expense | 921 | 3,480 | 2,249 | (18,842) | | Minority Interest | 2,325 |
-
|
-
| (155) | | | | Net Income From Continuing Ops | 9,106 | (33,310) | (12,089) | (33,018) | | | Non-recurring Events | | Discontinued Operations | 1,846 | (325) | 264 | 303 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,277 | (33,635) | (11,825) | (32,715) | | Preferred Stock And Other Adjustments | (1,852) | (1,696) | 3,548 |
-
| | | Net Income Applicable To Common Shares | $11,425 | ($35,331) | ($8,277) | ($32,715) |
|
0.03% Nasdaq 
0.36%
Income Statement
